Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly EPS (Basic) of -$1.01 for Q2 2026, down 350.3% year-over-year from $0.4 in Q2 2025, and down 1272.6% on a QoQ basis from -$0.07 in Q4 2025.
Supernus Pharmaceuticals (SUPN) EPS (Basic) (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported EPS (Basic) for 16 years, with the latest figure at -$1.01 in Q2 2026.
- EPS (Basic) for Q2 2026 came in at -$1.01, down 350.3% year-over-year; the trailing twelve-month figure through Jun 2026 was -$1.85 (down 260.87% YoY), and the FY2025 annual result was -$0.68, down 150.94% from the prior year.
- EPS (Basic) eased to -$1.01 in Q2 2026, from -$0.07 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.7 in Q3 2024 and troughed at -$1.01 in Q2 2026.
- A 5-year average of $0.05 and a median of $0.03 in 2022 frame the typical range for EPS (Basic).
- The widest annual swing landed in 2024, when EPS (Basic) soared 2485.7%; it then sank 9459.59% in 2025.
- A 5-year view of EPS (Basic) shows it stood at $0.47 in 2022, then slumped by 95.46% to $0.02 in 2023, then soared by 1195.29% to $0.28 in 2024, then slumped by 126.24% to -$0.07 in 2025, then sank by 1272.6% to -$1.01 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$1.01 in Q2 2026, -$0.07 in Q4 2025, and -$0.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | -1.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.80 |
| Jun 30, 2025 | 0.40 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | 0.70 |
| Jun 30, 2024 | 0.36 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.29 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | 0.31 |
| Dec 31, 2022 | 0.48 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.15 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.05 |
| Sep 30, 2021 | 0.41 |
| Jun 30, 2021 | 0.45 |